Patient#	Sample#	Ephrin A1/EPHA2:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),	SEC6/SEC8:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),(nectin-2(dimer)/I-afadin/I-afadin/nectin-2(dimer/I-afadin/I-afadin, active),	Wnt receptor signaling pathway:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),	cortical microtubule organization:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),	epithelial cell differentiation:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),	Ephrin A1/EPHA2/NCK1/GIT1:(Ephrin A1/EPHA2, active),(NCK1/GIT1, active),	ACTN1:(ACTN1, protein),(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),	EGF:(EGF, protein),	HGF:(HGF, protein),	IGF1:(IGF1, protein),	KIF3C:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),(KIF3C, protein),	LIMA1:(LIMA1, protein),	MET:(MET, protein),	MGAT3:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),(MGAT3, protein),	Myosin VI:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),(Myosin VI, protein),	PIP5K1C:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),(PIP5K1C, protein),	PLEKHA7:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),(PLEKHA7, protein),	STX4:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),(STX4, protein),	ZYX:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),(ZYX, protein),	E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),(LIMA1, active),	EGFR:(EGFR, protein),	HGF/MET:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),(HGF, active),(MET, active),	KIAA1543:(KIAA1543, protein),(PLEKHA7, active),	LPP:(ACTN1, active),(LPP, protein),	IGF-1R heterotetramer/IGF1:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),(IGF-1R heterotetramer, active),(IGF1, active),	PI-4-5-P2:(PI-4-P, active),(PIP5K1C, active),	VCL:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),(Myosin VI, active),(VCL, protein),	establishment of epithelial cell apical/basal polarity:(SEC6/SEC8, active),(STX4, active),	regulation of calcium-dependent cell-cell adhesion:(MGAT3, active),	E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN/cortical actin cytoskeleton:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN, active),(cortical actin cytoskeleton, active),	EGFR/EGFR/EGF/EGF:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),(EGF, active),(EGFR, active),	VASP:(LPP, active),(VASP, protein),(ZYX, active),	actin cytoskeleton organization:(VCL, active),	exocyst:(PI-4-5-P2, active),(exocyst, protein),	cortical actin cytoskeleton stabilization:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN/cortical actin cytoskeleton, active),	AQP3	AQP5:(AQP3, active),(AQP5, protein),	ARF6/GDP	DIAPH1	adherens junction assembly:(DIAPH1, active),(KIAA1543, active),(KIF3C, active),(PI-4-5-P2, active),	ENAH	actin cable formation:(DIAPH1, active),(ENAH, active),(VASP, active),	GDP	GTP:(ARF6/GTP, active),(GDP, active),	RhoA/GTP:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin, active),(GTP, active),(RhoA/GDP, active),	ROCK1:(ROCK1, protein),(RhoA/GTP, active),	myosin II complex:(ROCK1, active),	adherens junction organization:(E-cadherin/Ca2+/beta catenin/alpha catenin/p120 catenin/EPLIN/cortical actin cytoskeleton, active),(myosin II complex, active),	regulation of cell-cell adhesion:(VCL, active),(myosin II complex, active),	
